{"id":"https://openalex.org/W1976554010","doi":"https://doi.org/10.2165/00126839-200506050-00001","title":"Eslicarbazepine Acetate (BIA 2-093): Relative Bioavailability and Bioequivalence of 50 mg/mL Oral Suspension and 200mg and 800mg Tablet Formulations","display_name":"Eslicarbazepine Acetate (BIA 2-093): Relative Bioavailability and Bioequivalence of 50 mg/mL Oral Suspension and 200mg and 800mg Tablet Formulations","publication_year":2005,"publication_date":"2005-01-01","ids":{"openalex":"https://openalex.org/W1976554010","doi":"https://doi.org/10.2165/00126839-200506050-00001","mag":"1976554010","pmid":"https://pubmed.ncbi.nlm.nih.gov/16128595"},"language":"en","primary_location":{"id":"doi:10.2165/00126839-200506050-00001","doi":"https://doi.org/10.2165/00126839-200506050-00001","is_oa":false,"landing_page_url":"https://doi.org/10.2165/00126839-200506050-00001","pdf_url":null,"source":{"id":"https://openalex.org/S35266406","display_name":"Drugs in R&D","issn_l":"1174-5886","issn":["1174-5886","1179-6901"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs in R & D","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005407396","display_name":"Carlos Ribeiro","orcid":"https://orcid.org/0000-0002-9707-4895","observed_orcids":["https://orcid.org/0000-0002-9707-4895"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carlos Fontes-Ribeiro","raw_affiliation_strings":["CEB - Centre for Bioavailability Studies, Coimbra, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CEB - Centre for Bioavailability Studies, Coimbra, Portugal","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Teresa Nunes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I108511484","display_name":"Bial (Portugal)","ror":"https://ror.org/02htdjb57","country_code":"PT","type":"company","lineage":["https://openalex.org/I108511484"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Teresa Nunes","raw_affiliation_strings":["R&D Department, and Pharmaceutical Development Laboratory, BIAL (Portela & Ca SA), S. Mamede do Coronado, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"R&D Department, and Pharmaceutical Development Laboratory, BIAL (Portela & Ca SA), S. Mamede do Coronado, Portugal","institution_ids":["https://openalex.org/I108511484"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110179739","display_name":"Amilcar Falc o","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I108511484","display_name":"Bial (Portugal)","ror":"https://ror.org/02htdjb57","country_code":"PT","type":"company","lineage":["https://openalex.org/I108511484"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Amilcar Falc??o","raw_affiliation_strings":["R&D Department, and Pharmaceutical Development Laboratory, BIAL (Portela & Ca SA), S. Mamede do Coronado, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"R&D Department, and Pharmaceutical Development Laboratory, BIAL (Portela & Ca SA), S. Mamede do Coronado, Portugal","institution_ids":["https://openalex.org/I108511484"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062833695","display_name":"Carla Neta","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carla Neta","raw_affiliation_strings":["CEB - Centre for Bioavailability Studies, Coimbra, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CEB - Centre for Bioavailability Studies, Coimbra, Portugal","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102872071","display_name":"Ricardo Lima","orcid":"https://orcid.org/0000-0003-3692-0717","observed_orcids":["https://orcid.org/0000-0003-3692-0717"]},"institutions":[{"id":"https://openalex.org/I108511484","display_name":"Bial (Portugal)","ror":"https://ror.org/02htdjb57","country_code":"PT","type":"company","lineage":["https://openalex.org/I108511484"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Ricardo Lima","raw_affiliation_strings":["R&D Department, and Pharmaceutical Development Laboratory, BIAL (Portela & Ca SA), S. Mamede do Coronado, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"R&D Department, and Pharmaceutical Development Laboratory, BIAL (Portela & Ca SA), S. Mamede do Coronado, Portugal","institution_ids":["https://openalex.org/I108511484"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Susana Tavares","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I108511484","display_name":"Bial (Portugal)","ror":"https://ror.org/02htdjb57","country_code":"PT","type":"company","lineage":["https://openalex.org/I108511484"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Susana Tavares","raw_affiliation_strings":["R&D Department, and Pharmaceutical Development Laboratory, BIAL (Portela & Ca SA), S. Mamede do Coronado, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"R&D Department, and Pharmaceutical Development Laboratory, BIAL (Portela & Ca SA), S. Mamede do Coronado, Portugal","institution_ids":["https://openalex.org/I108511484"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023609484","display_name":"Lu\u00eds Almeida","orcid":"https://orcid.org/0000-0002-4861-8649","observed_orcids":["https://orcid.org/0000-0002-4861-8649"]},"institutions":[{"id":"https://openalex.org/I108511484","display_name":"Bial (Portugal)","ror":"https://ror.org/02htdjb57","country_code":"PT","type":"company","lineage":["https://openalex.org/I108511484"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Luis Almeida","raw_affiliation_strings":["R&D Department, and Pharmaceutical Development Laboratory, BIAL (Portela & Ca SA), S. Mamede do Coronado, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"R&D Department, and Pharmaceutical Development Laboratory, BIAL (Portela & Ca SA), S. Mamede do Coronado, Portugal","institution_ids":["https://openalex.org/I108511484"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111800347","display_name":"Tice Macedo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tice Macedo","raw_affiliation_strings":["CEB - Centre for Bioavailability Studies, Coimbra, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CEB - Centre for Bioavailability Studies, Coimbra, Portugal","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078712323","display_name":"Patr\u00edcio Soares-da-Silva","orcid":"https://orcid.org/0000-0002-2446-5078","observed_orcids":["https://orcid.org/0000-0002-2446-5078"]},"institutions":[{"id":"https://openalex.org/I108511484","display_name":"Bial (Portugal)","ror":"https://ror.org/02htdjb57","country_code":"PT","type":"company","lineage":["https://openalex.org/I108511484"]}],"countries":["PT"],"is_corresponding":true,"raw_author_name":"Patricio Soares-da-Silva","raw_affiliation_strings":["R&D Department, and Pharmaceutical Development Laboratory, BIAL (Portela & Ca SA), S. Mamede do Coronado, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"R&D Department, and Pharmaceutical Development Laboratory, BIAL (Portela & Ca SA), S. Mamede do Coronado, Portugal","institution_ids":["https://openalex.org/I108511484"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5078712323"],"corresponding_institution_ids":["https://openalex.org/I108511484"],"apc_list":{"value":3490,"currency":"USD","value_usd":3490},"apc_paid":null,"fwci":1.0693,"has_fulltext":false,"cited_by_count":19,"citation_normalized_percentile":{"value":0.75417576,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"6","issue":"5","first_page":"253","last_page":"260"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.7064999938011169,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.7064999938011169,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.06589999794960022,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.05869999900460243,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/eslicarbazepine-acetate","display_name":"eslicarbazepine acetate","score":0.9980000257492065},{"id":"https://openalex.org/keywords/bioequivalence","display_name":"bioequivalence","score":0.8930000066757202},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.890999972820282},{"id":"https://openalex.org/keywords/oral-suspension","display_name":"oral suspension","score":0.640999972820282},{"id":"https://openalex.org/keywords/tablet-formulation","display_name":"tablet formulation","score":0.6800000071525574},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.722000002861023},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.4659999907016754},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.5699999928474426},{"id":"https://openalex.org/keywords/crossover-design","display_name":"crossover design","score":0.4779999852180481},{"id":"https://openalex.org/keywords/auc-and-cmax-comparison","display_name":"AUC and Cmax comparison","score":0.7730000019073486},{"id":"https://openalex.org/keywords/generic-drug-comparison","display_name":"generic drug comparison","score":0.36000001430511475},{"id":"https://openalex.org/keywords/epilepsy-treatment","display_name":"epilepsy treatment","score":0.546999990940094}],"concepts":[{"id":"https://openalex.org/C42404028","wikidata":"https://www.wikidata.org/wiki/Q864940","display_name":"Bioequivalence","level":3,"score":0.8142483234405518},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.6722068786621094},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.6487790942192078},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.6102944612503052},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.5950470566749573},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5038873553276062},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.34165287017822266},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.31806284189224243},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.29540178179740906},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22635701298713684},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.12151774764060974},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003984","descriptor_name":"Dibenzazepines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003984","descriptor_name":"Dibenzazepines","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003984","descriptor_name":"Dibenzazepines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013535","descriptor_name":"Suspensions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013607","descriptor_name":"Tablets","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013810","descriptor_name":"Therapeutic Equivalency","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2165/00126839-200506050-00001","doi":"https://doi.org/10.2165/00126839-200506050-00001","is_oa":false,"landing_page_url":"https://doi.org/10.2165/00126839-200506050-00001","pdf_url":null,"source":{"id":"https://openalex.org/S35266406","display_name":"Drugs in R&D","issn_l":"1174-5886","issn":["1174-5886","1179-6901"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs in R & D","raw_type":"journal-article"},{"id":"pmid:16128595","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16128595","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs in R&D","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W1971452852","https://openalex.org/W1995660607","https://openalex.org/W2024607510","https://openalex.org/W2037698344","https://openalex.org/W2040273455","https://openalex.org/W2114440648","https://openalex.org/W2154604038"],"related_works":["https://openalex.org/W2125187289","https://openalex.org/W2075389669","https://openalex.org/W7101011262","https://openalex.org/W2181810641","https://openalex.org/W39094740","https://openalex.org/W1994747051","https://openalex.org/W2320413307","https://openalex.org/W2512969852","https://openalex.org/W1971452852","https://openalex.org/W1980468546"],"abstract_inverted_index":null,"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-13T13:42:25.865203","created_date":"2016-06-24T00:00:00"}